CTS Corp 3Q 2026: Revenue $149.6M, EPS $0.61— 10-Q Summary

What happened

CTS Corp reported third-quarter 2026 revenue of $149.6 million, up 4.6% from $143 million a year earlier. Net income rose to $17.8 million from $13.7 million, and diluted earnings per share increased to $0.61 from $0.46.

Confirmed

Global impact / market context

Higher sales and an improved gross margin, which means the profit left after direct product costs, show CTS kept more profit per sale while growing revenue. That combination supports earnings and gives the company more cash available to fund acquisitions and investment.

Analyst inference

Growth was led by medical and industrial demand over nine months, while aerospace and defense sales fell on contract award timing. CTS also bought Millar, a medical pressure-sensor maker, in October, adding exposure to medical sensing markets.

Analyst inference

What to watch

1. CTS acquired Millar, a medical pressure-sensor maker, in October, adding sensing capabilities and reach in medical markets, and is investing in sensing, connectivity, motion technologies, products and talent. Confirmed
2. Watch whether medical and industrial demand keeps driving sales growth while aerospace and defense orders recover, since contract award timing caused that segment's decline. Proposed
3. Track whether the 42.2% gross margin holds, as it relied partly on favorable foreign exchange, which means currency moves that may not repeat and could pressure costs later. Analyst inference

Evidence

• Original source link unavailable